Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Clinics in Geriatric MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Biomarkers in Prodromal Parkinson disease: a Qualitative review.J Int Neuropsychol Soc. 2016; 22: 956-967
- Fluid and PET biomarkers for amyloid pathology in Alzheimer’s disease.Mol Cell Neurosci. 2019; 97: 3-17
- An expanded role for neuroimaging in the evaluation of memory impairment.AJNR Am J Neuroradiol. 2013; 34: 2075-2082
- Diffusion-weighted and fluid-attenuated inversion recovery imaging in Creutzfeldt-Jakob disease: high sensitivity and specificity for diagnosis.AJNR Am J Neuroradiol. 2005; 26: 1551-1562
- Magnetic resonance imaging and computed tomography of the brain—50 Years of Innovation, with a Focus on the Future.Invest Radiol. 2015; 50: 551
- 11C-methionine PET for grading and prognostication in gliomas: a comparison study with 18F-FDG PET and contrast enhancement on MRI.J Nucl Med. 2012; 53: 1709-1715
- Normal Press Hydrocephalus. Continuum . 2019; 25: 165-186
- Imaging brain amyloid in Alzheimer’s disease with Pittsburgh Compound-B.Ann Neurol. 2004; 55: 306-319
- Appropriate use criteria for amyloid PET: a report of the amyloid imaging task Force, the Society of nuclear Medicine and molecular imaging, and the Alzheimer’s association.Alzheimers Dement. 2013; 9: e.1-16
- In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18).J Nucl Med. 2010; 51: 913-920
- Florbetapir-PET imaging and postmortem beta-amyloid pathology.JAMA. 2011; 305 ([author reply: 1857–8]): 1857
- Use of florbetapir-PET for imaging beta-amyloid pathology.JAMA. 2011; 305: 275-283
- Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study.Lancet Neurol. 2007; 6: 305-313
- Diagnostic accuracy of DAT-SPECT and MIBG scintigraphy for dementia with Lewy bodies: an updated systematic review and Bayesian latent class model meta-analysis.Eur J Nucl Med Mol Imaging. 2020; 47: 1984-1997
- PET imaging of the dopamine transporter in progressive supranuclear palsy and Parkinson’s disease.Neurology. 1999; 52: 1221-1226
- Diagnostic performance of 123I-FPCIT SPECT specific binding ratio in progressive supranuclear palsy: use of core clinical features and MRI for comparison.AJR Am J Roentgenol. 2020; 215: 1443-1448
- Differential diagnosis of parkinsonian syndromes using dopamine transporter and perfusion SPECT.Parkinsonism Relat Disord. 2018; 47: 15-21
- Topography of dopamine transporter availability in progressive supranuclear palsy: a voxelwise [123I]beta-CIT SPECT analysis.Arch Neurol. 2006; 63: 1154-1160
- The role of functional dopamine-transporter SPECT imaging in parkinsonian syndromes, part 1.AJNR Am J Neuroradiol. 2015; 36: 229-235
- Dopamine transporter SPECT imaging in corticobasal syndrome.PLoS One. 2011; 6e18301
- Role of neuroimaging on differentiation of Parkinson’s disease and its related diseases.Yonago Acta Med. 2018; 61: 145-155
- Aphasia, memory loss, and other focal cerebral disorders. Harrison’s Principles of Internal Medicine.21st edition. 2022 (in press)
- Dissociable intrinsic connectivity networks for salience processing and executive control.J Neurosci. 2007; 27: 2349-2356
- Executive dysfunction.Continuum. 2015; 21: 646-659
- Representation, inference, and transcendent encoding in neurocognitive networks of the human brain.Ann Neurol. 2008; 64: 367-378
- Harrison’s principles of internal Medicine.McGraw Hill, New York2022
- Neuroimaging of normal pressure hydrocephalus and hydrocephalus.Neurol Clin. 2020; 38: 171-183
- Computerized tomography findings in Fahr’s syndrome.Arq Neuropsiquiatr. 2004; 62: 789-792
- Huntington’s disease: brain imaging in Huntington's disease.Prog Mol Biol Transl Sci. 2019; 165: 321-369
- Neuroimaging in dementia.Semin Neurol. 2017; 37: 510-537
- Four-repeat tauopathies: current Management and Future treatments.Neurotherapeutics. 2020; 17: 1563-1581
- The midbrain to pons ratio: a simple and specific MRI sign of progressive supranuclear palsy.Neurology. 2013; 80: 1856-1861
- Rapidly progressive dementia.Continuum. 2016; 22: 510-537
- MRI of Creutzfeldt-Jakob disease: imaging features and recommended MRI protocol.Clin Radiol. 2001; 56: 726-739
- Neuropathologically defined subtypes of Alzheimer’s disease with distinct clinical characteristics: a retrospective study.Lancet Neurol. 2011; 10: 785-796
- Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer’s Disease Neuroimaging Initiative (ADNI).Neuroimage. 2009; 45: 1107-1116
- Comparison of the diagnostic performance of FDG-PET and VBM-MRI in very mild Alzheimer’s disease.Eur J Nucl Med Mol Imaging. 2006; 33: 801-809
- Memory in multiple sclerosis: a reappraisal using the item specific deficit approach.Neuropsychology. 2021; 35: 207-219
- Quantitative MRI demonstrates abnormality of the fornix and cingulum in multiple sclerosis.Mult Scler Int. 2013; 2013: 838719
- Neuroimaging of the Wernicke-Korsakoff syndrome.Alcohol Alcohol. 2009; 44: 155-165
- Manual of aphasia and aphasia Therapy.PRO-ED, New York2014
- Age and aphasia: a review of presence, type, recovery and clinical outcomes.Top Stroke Rehabil. 2016; 23: 430-439
- Small vessel disease: mechanisms and clinical implications.Lancet Neurol. 2019; 18: 684-696
- Association of inflammatory markers with cerebral small vessel disease in community-based population.J Neuroinflammation. 2022; 19: 106
- Diffuse leukoencephalopathy with spheroids presenting as primary progressive aphasia.Neurology. 2015; 85: 652-653
- Creutzfeldt-jakob and vascular brain diseases: their Overlap and relationships.Front Neurol. 2021; 12: 613991
- Creutzfeldt-jakob disease presenting as expressive aphasia and nonconvulsive Status epilepticus.Case Rep Crit Care. 2018; 2018: 5053175
- Sleep talking and primary progressive aphasia: case study and autopsy findings in a patient with logopenic primary progressive aphasia and dementia with Lewy bodies.BMJ Case Rep. 2019; 12https://doi.org/10.1136/bcr-2018-228938
- Primary progressive aphasia as a Prodromal state of dementia with Lewy bodies: a case report.Front Neurol. 2020; 11https://doi.org/10.3389/fneur.2020.00049
- Early-onset Alzheimer disease and its variants.Continuum. 2019; 25: 34-51
- Pathologic correlates of diffusion MRI changes in Creutzfeldt-Jakob disease.Neurology. 2009; 72: 1425-1431
- The clinical approach to the identification of higher-order visual dysfunction in neurodegenerative disease.Curr Neurol Neurosci Rep. 2022; 22: 229-242
Article info
Publication history
Published online: October 18, 2022
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
